Japan Researchers Said To Violate Ethics In Blood Study
This article was originally published in PharmAsia News
Japanese researchers who published a study on molecular treatments for blood disorders such as leukemia apparently falsified their report, according to University of Tokyo officials. Officials said the researchers failed to follow ethics guidelines in conducting their study, which included drawing bone marrow and peripheral blood from five acute myeloid leukemia patients without their permission and without ethics board approval. The school said the investigation would continue and the article in question had been retracted. (Click here for more
You may also be interested in...
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.